Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139766

Published: 2020

Journal Articles

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139623

Published: 2020

Journal Articles

Polatuzumab Vedotin-Based Salvage Chemotherapy in the Third-Line or Above Treatment for Diffuse Large B-Cell Lymphoma

Cheng-Hong Tsai, MD MSc, Feng Ming Tien, MD MSc, Hsin-An Hou, MD PhD, Jia-Hau Liu, MD, Shang-Ju Wu, MD PhD, Yu-Wen Wang, MSc., Chien-Chin Lin, MD, Bor-Sheng Ko, MD PhD, Wen-Chien Chou, MD PhD, Yun-Chu Lin, MD, Chieh-Lung Cheng, MD, Li-Chun Lu, MD PhD, Sung-Hsin Kuo, MD PhD, Ruey-Long Hong, MD PhD, Tai-Chung Huang, MD PhD, Ming Yao, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138481

Published: 2020

Journal Articles

Next-Generation Sequencing Minimal Residual Disease of Mantle Cell Lymphoma in Autologous Stem Cell Grafts and Its Implication on Tumor Recurrence

Yu-Hung Wang, MD, Yi-Kuang Chuang, Yu-Hsuan Yang, Shan-Chi Yu, Yi-Tsung Yang, Bor-Sheng Ko, MD PhD, Ming Yao, MD, Tai-Chung Huang, MD PhD, Jih-Luh Tang, MD, PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-142247

Published: 2020

Journal Articles

Anti-Viral Prophylaxis for Hepatitis B Virus Is Associated with Improved Outcome in Patients with Diffuse Large B Cell Lymphoma in Taiwan - a Population-Based Study between 2011 and 2015

Huai-Hsuan Huang, Fei-Yuan Hsiao, PhD Associate Professor, Ho-Min Chen, M.S., Chen-Yu Wang, PhD, Hwei-Fang Tien, MD, PhD, Bor-Sheng Ko, MD PhD

Blood (2019) 134 (Supplement_1): 4765.

https://doi.org/10.1182/blood-2019-127972

Published: 2019

Journal Articles

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

Blood (2018) 132 (Supplement 1): 3977.

https://doi.org/10.1182/blood-2018-99-114315

Published: 2018

Journal Articles

A Case-Control Study to Compare the Survival Benefits of Patients Who Suffer from Peripheral T-Cell Lymphoma (PTCL) Treated with Chidamide, a Histone Deacetylase Inhibitor, in China with a Historical Matched Cohort of Patients Treated with Conventional Therapy in Taiwan: Survival Advantage Is Demonstrated

Bor-Sheng Ko, MD PhD, Su-Peng Yeh, MD, Hsiao-Wen Kao, MD, Yuan-Bin Yu, MD, Shyh-Tyan Ou, PhD, Cheng-Shyong Chang, MD

Blood (2018) 132 (Supplement 1): 5367.

https://doi.org/10.1182/blood-2018-99-114738

Published: 2018

Journal Articles

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Chih-Chuan Lu, B.S., Jeng-Lin Li, BS, Chi-Chun Lee, PhD, Jih-Luh Tang, MD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 2811.

https://doi.org/10.1182/blood-2018-99-115778

Published: 2018

Journal Articles

The Clinical and Biological Implications of Aberrant Alternative Splicing in Patients with De Novo, Non-M3 Acute Myeloid Leukemia

Chiu Po-Ju, MD, Yi-Tsung Yang, Yu-Chiao Chiu, PhD, Hsin-An Hou, MD, PhD, Jih-Luh Tang, MD,PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Woei Tsai, MD, PhD, Yidong Chen, PhD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 1382.

https://doi.org/10.1182/blood.V130.Suppl_1.1382.1382

Published: 2017

Journal Articles

The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia

Jui-Che Chen, MD, Cheng-Hong Tsai, MD, M.Sc., Jih-Luh Tang, MD,PhD, Yuan-Yeh Kuo, PhD, Chien-Chin Lin, MD, Mei-Hsuan Tseng, M.Sc., Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Chien-Yuan Chen, MD, PhD, Woei Tsai, MD, PhD, Wen-Chien Chou, MD, PhD, Hsin-An Hou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 1300.

https://doi.org/10.1182/blood.V130.Suppl_1.1300.1300

Published: 2017

Journal Articles

An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry

Bor-Sheng Ko, MD, PhD, Chi-Cheng Li, MD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, MD, PhD, Pei-Fang Weng, BS, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 1403.

https://doi.org/10.1182/blood.V130.Suppl_1.1403.1403

Published: 2017

Journal Articles

An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data

Yu-Fen Wang, MS, Bor-Sheng Ko, MD, PhD, Chi-Cheng Li, MD, Jeng-Lin Li, BS, Pei-Fang Weng, BS, Huai-Hsuan Huang, MD, Hsin-An Hou, MD, PhD, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 3980.

https://doi.org/10.1182/blood.V130.Suppl_1.3980.3980

Published: 2017

Journal Articles

The Implications of Endoplasmic Reticulum Stress Response in the Prognosis and Pathogenesis of Myelodysplastic Syndrome

Ming-En Lin, MD, Wen-Chien Chou, MD, PhD, Yu-Chiao Chiu, PhD, Mei-Hsuan Tseng, M.Sc., Ming-Chih Liu, Chia-Wen Liu, Jih-Luh Tang, MD,PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Chien-Yuan Chen, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu-Chun Hsu, MD, Hsin-An Hou, MD, PhD, Shang-Ju Wu, MD, PhD, Chien-Ting Lin, MD, Woei Tsai, MD, PhD, Yidong Chen, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 4249.

https://doi.org/10.1182/blood.V130.Suppl_1.4249.4249

Published: 2017

Journal Articles

Prognostic Impacts and Dynamic Changes of Cohesin Complex Gene Mutations in De Novo Acute Myeloid Leukemia

Cheng-Hong Tsai, MD, M.Sc., Hsin-An Hou, MD, PhD, Jih-Luh Tang, MD,PhD, Yuan-Yeh Kuo, PhD, Yu-Chiao Chiu, PhD, Chien-Chin Lin, MD, Liang-In Lin, PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, PhD, Szu Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD, PhD, Chien-Yuan Chen, MD, PhD, Woei Tsai, MD, PhD, Wen-Chien Chou, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2017) 130 (Supplement 1): 2582.

https://doi.org/10.1182/blood.V130.Suppl_1.2582.2582

Published: 2017

Journal Articles

An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data

Chi-Cheng Li, MD, Bor-Sheng Ko, MD, PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Pei-Fang Weng, BS, Hsin-An Hou, MD, PhD, Xiu-Wen Liao, MS, Chien-Ting Lin, MD, Jia-Hou Liu, MD, Hsun-I Sun, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 2042.

https://doi.org/10.1182/blood.V130.Suppl_1.2042.2042

Published: 2017

Journal Articles

A Nationwide Real-World Analysis for the Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma in Taiwan

Huai-Hsuan Huang, MD, Yao-Chun Wen, M.S., Ho-Min Chen, M.S., Hwei-Fang Tien, MD, PhD, Fei-Yuan Hsiao, PhD Associate Professor, Bor-Sheng Ko, MD, PhD

Blood (2017) 130 (Supplement 1): 5169.

https://doi.org/10.1182/blood.V130.Suppl_1.5169.5169

Published: 2017

Journal Articles

Aberrant Patterns of Alternative Splicing Are Frequent Events and Harbor Prognostic Significance in Patients with Myelodysplastic Syndrome

Yi-Tsung Yang, Wen-Chien Chou, MD PhD, Yu-Chiao Chiu, Hsin-An Hou, MD PhD, Jih-Luh Tang, MD PhD, Ming Yao, MD, Chi-Cheng Li, MD, Shang-Yi Huang, Bor-Sheng Ko, MD PhD, Chien-Yuan Chen, MD PhD, Szu-Chun Hsu, MD, Chien-Ting Lin, MD, Shang-Ju Wu, MD PhD, Woei Tsay, MD PhD, Hwei-Fang Tien, MD PhD

Blood (2016) 128 (22): 49.

https://doi.org/10.1182/blood.V128.22.49.49

Published: 2016

Journal Articles

The Clinical Characteristics, Genetic Alterations and Prognostic Significance of De Novo Acute Myeloid Leukemia (AML) with Hyperleukocytosis (HL)

Feng-Ming Tien, MD, Hsin-An Hou, MD PhD, Chien-Yuan Chen, MD PhD, Wen-Chien Chou, MD PhD, Chi-Cheng Li, MD, Chien-Ting Lin, MD, Ming Yao, MD, Shang-Yi Huang, MD PhD, Bor-Sheng Ko, MD PhD, Szu-Chun Hsu, MD, Shang-Ju Wu, MD PhD, Woei Tsay, MD PhD, Jih-Luh Tang, MD PhD, Hwei-Fang Tien, MD PhD

Blood (2016) 128 (22): 2860.

https://doi.org/10.1182/blood.V128.22.2860.2860

Published: 2016

Journal Articles

Higher Expression of Suppressor of Cytokine Signaling1 ( SOCS1 ) in the Bone Marrow Is an Unfavorable Prognostic Factor in Adult Patients with De Novo Acute Myeloid Leukemia

Cheng-Hong Tsai, MD, Hwei-Fang Tien, MD PhD, Hsin-An Hou, MD PhD, Wen-Chien Chou, MD PhD, Yan-Jun Lai, Yuan-Yeh Kuo, PhD, Chien-Yuan Chen, MD PhD, Jih-Luh Tang, MD PhD, Ming Yao, MD, Shang-Yi Huang, Bor-Sheng Ko, MD PhD, Szu-Chun Hsu, MD, Shang-Ju Wu, MD PhD, Woei Tsay, MD PhD, Yao-Chang Chen, MDPhD, Mei-Hsuan Tseng, Chi-Fei Huang

Blood (2014) 124 (21): 1034.

https://doi.org/10.1182/blood.V124.21.1034.1034

Published: 2014

Journal Articles

Paired Samples Analyses Of GATA2 mutations During Clinical Follow-Ups In 138 Patients With Acute Myeloid Leukemia-The Mutation Is Unstable During Disease Evolution

Yun-Chu Lin, Hsin-An Hou, MD, Wen-Chien Chou, MD, PhD, Chien-Yuan Chen, MD, Jih-Luh Tang, MD, PhD, Ming Yao, MD, Shang-Yi Huang, MD, PhD, Bor-Sheng Ko, MD, Szu-Chun Hsu, MD, Shang-Ju Wu, MD, Woei Tsay, MD, PhD, Yao-Chang Chen, MD, PhD, Hwei-Fang Tien, MD, PhD

Blood (2013) 122 (21): 2498.

https://doi.org/10.1182/blood.V122.21.2498.2498

Published: 2013

NARROW

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Polatuzumab Vedotin-Based Salvage Chemotherapy in the Third-Line or Above Treatment for Diffuse Large B-Cell Lymphoma

Next-Generation Sequencing Minimal Residual Disease of Mantle Cell Lymphoma in Autologous Stem Cell Grafts and Its Implication on Tumor Recurrence

Anti-Viral Prophylaxis for Hepatitis B Virus Is Associated with Improved Outcome in Patients with Diffuse Large B Cell Lymphoma in Taiwan - a Population-Based Study between 2011 and 2015

Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novo aml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3 -ITD Patients

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

The Clinical and Biological Implications of Aberrant Alternative Splicing in Patients with De Novo, Non-M3 Acute Myeloid Leukemia

The Clinical Implication and Prognostic Impact of Dynamic Molecular Evolution in Acute Myeloid Leukemia

An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry

An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data

The Implications of Endoplasmic Reticulum Stress Response in the Prognosis and Pathogenesis of Myelodysplastic Syndrome

Prognostic Impacts and Dynamic Changes of Cohesin Complex Gene Mutations in De Novo Acute Myeloid Leukemia

An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data

A Nationwide Real-World Analysis for the Effectiveness of Rituximab Maintenance in Patients with Follicular Lymphoma in Taiwan

Aberrant Patterns of Alternative Splicing Are Frequent Events and Harbor Prognostic Significance in Patients with Myelodysplastic Syndrome

The Clinical Characteristics, Genetic Alterations and Prognostic Significance of De Novo Acute Myeloid Leukemia (AML) with Hyperleukocytosis (HL)

Higher Expression of Suppressor of Cytokine Signaling1 ( SOCS1 ) in the Bone Marrow Is an Unfavorable Prognostic Factor in Adult Patients with De Novo Acute Myeloid Leukemia

Paired Samples Analyses Of GATA2 mutations During Clinical Follow-Ups In 138 Patients With Acute Myeloid Leukemia-The Mutation Is Unstable During Disease Evolution

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only